{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-006811","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2022-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.837911+00:00","generated_at":"2026-06-26T22:50:20.714293+00:00","sec_items":["7.01","8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Co-Diagnostics announces $30M share repurchase program","bullets":["Board authorized up to $30 million of common stock repurchases.","Program is discretionary; company not obligated to buy any specific number of shares.","Management cites strong balance sheet and cash flow generation as supporting the buyback.","Repurchases may be made via open market, block trades, or Rule 10b5-1 plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-006811","json":"https://secwatch.observer/filing/0001493152-22-006811.json","markdown":"https://secwatch.observer/filing/0001493152-22-006811.md","text":"https://secwatch.observer/filing/0001493152-22-006811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315222006811/0001493152-22-006811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315222006811/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:50:20.714293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}